Pfizer (PFE) capital expenditure was $2.6B in FY2025 (-10% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$2.6B
-10%
2024
$2.9B
-26%
2023
$3.9B
+21%
2022
$3.2B
+19%
2021
$2.7B
-2%
2020
$2.8B
+12%
2019
$2.5B
+15%
2018
$2.1B
-4%
2017
$2.2B
+11%
2016
$2.0B
+34%
2015
$1.5B
-5%
2014
$1.6B
+8%
2013
$1.5B
+3%
2012
$1.4B
-25%
2011
$1.9B
+24%
2010
$1.5B
+26%
2009
$1.2B
-29%
2008
$1.7B
-10%
2007
$1.9B
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q2 2026
$533M
Q1 2026
$436M
Q4 2025
$845M
Q3 2025
$602M
Q2 2025
$618M
Q1 2025
$564M
Q4 2024
$917M
Q3 2024
$651M
Q2 2024
$637M
Q1 2024
$704M
Q4 2023
$1.0B
Q3 2023
$810M
Source: PFE on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.